Genfit S.A. (MUN:XUPB)
Germany · Delayed Price · Currency is EUR 8.80
+1.05 (13.55%)
Inactive · Last trade price on Mar 10, 2026
Genfit Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 101.09 | 81.79 | 77.79 | 136 | 258.76 |
Short-Term Investments | - | - | - | 4.55 | - |
Cash & Short-Term Investments | 101.09 | 81.79 | 77.79 | 140.55 | 258.76 |
Cash Growth | 23.60% | 5.14% | -44.65% | -45.68% | 51.29% |
Accounts Receivable | 40.33 | 7.56 | 32.71 | 15.91 | 7.24 |
Inventory | 0 | 0 | 0 | 0 | - |
Other Current Assets | 2.86 | 3.41 | 2.62 | 2 | 2.1 |
Total Current Assets | 144.28 | 92.77 | 113.12 | 158.46 | 268.1 |
Net Property, Plant & Equipment | 7.1 | 7.6 | 7.87 | 8.21 | 9.02 |
Other Intangible Assets | 4.16 | 48 | 48.76 | 43.96 | 0.17 |
Long-Term Investments | 3.5 | 3.07 | 4.13 | 4.91 | 4.43 |
Other Long-Term Assets | - | - | - | - | 0 |
Total Assets | 159.04 | 151.42 | 173.87 | 215.54 | 281.72 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 26.39 | 18.39 | 18.8 | 14.85 | 40.99 |
Accrued Expenses | 2.96 | 0.2 | 0.06 | 4.97 | 5.36 |
Current Portion of Long-Term Debt | 42.9 | 56.58 | 7.93 | 5.08 | 2.19 |
Unearned Revenue | 0.06 | - | 11.69 | 14.48 | 14.3 |
Total Current Liabilities | 72.31 | 75.16 | 38.48 | 39.37 | 62.84 |
Long-Term Debt | 107.79 | 5.55 | 62.25 | 70.2 | 72.05 |
Other Long-Term Liabilities | 1.48 | 1.49 | 5.19 | 11.45 | 27.74 |
Total Long-Term Liabilities | 109.27 | 7.04 | 67.44 | 81.64 | 99.79 |
Total Liabilities | 181.58 | 82.2 | 105.92 | 121.01 | 162.62 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 12.51 | 12.5 | 12.46 | 12.46 | 12.45 |
Additional Paid-in Capital | 440.3 | 446.95 | 445.26 | 444.68 | 444.44 |
Accumulated Other Comprehensive Income | 0.43 | 0.35 | 1 | -1.34 | 0.02 |
Retained Earnings | -475.78 | -390.57 | -390.76 | -361.27 | -337.82 |
Shareholders' Equity | -22.54 | 69.22 | 67.95 | 94.53 | 119.1 |
Total Liabilities & Equity | 159.04 | 151.42 | 173.87 | 215.54 | 281.72 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 150.69 | 62.13 | 70.18 | 75.28 | 74.24 |
Net Cash (Debt) | -49.6 | 19.66 | 7.61 | 65.28 | 184.52 |
Net Cash Growth | - | 158.25% | -88.34% | -64.62% | - |
Net Cash Per Share | -0.99 | 0.39 | 0.15 | 1.31 | 3.32 |
Book Value | -22.54 | 69.22 | 67.95 | 94.53 | 119.1 |
Book Value Per Share | -0.45 | 1.39 | 1.37 | 1.90 | 2.14 |
Tangible Book Value | -26.69 | 21.23 | 19.19 | 50.57 | 118.92 |
Tangible Book Value Per Share | -0.54 | 0.42 | 0.39 | 1.02 | 2.14 |